Prophylactical and therapeutical efficacy of Tiamuline in mycoplasmosis of chickens and turkeys.
To evaluate efficacy of Tiamuline in mycoplasmosis of chickens and turkeys under controlled field conditions 2 prophylactical and 3 therapeutical trials were conducted. The compound was administered via drinking water for 3 days in comparison to Tylosin tartrate. In both prophylactical and therapeutical tests, Tiamuline showed a superior efficiacy, as measured by clinical symptoms, pathological lesions and microbiological findings. Therefore, Tiamuline can be recommended for treatment of mycoplasmosis in chickens and turkeys in a dosage of 0.025% and in a dosage of 0.0125% for prophylaxis in flocks at risk.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002645:Chickens; D004224:Diterpenes / Q000627:therapeutic use; D005260:Female; D007933:Leucomycins / Q000627:therapeutic use; D009175:Mycoplasma Infections / Q000188:drug therapy / Q000517:prevention & control / Q000662:veterinary*; D011201:Poultry Diseases / Q000188:drug therapy* / Q000517:prevention & control; D014422:Turkeys
D000900:Anti-Bacterial Agents; D004224:Diterpenes; D007933:Leucomycins; C014224:tiamulin